ArticleExpression of programmed death ligand 1 (PD-L1) in urothelial bladder carcinoma (immunohistochemical and histopathological study)
ArticleExpression of programmed death ligand 1 (PD-L1) in urothelial bladder carcinoma (immunohistochemical and histopathological study)
ArticleAssessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics
ArticleAssessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics
ArticleSignificance of D2-40 and CXCL5 Expression in Urinary Bladder Transitional Cell Carcinoma: An Immunohistochemical Study
ArticleSignificance of D2-40 and CXCL5 Expression in Urinary Bladder Transitional Cell Carcinoma: An Immunohistochemical Study
ArticleRole of YAP1 and Tumor Associated Macrophages (TAMs) in Urothelial Carcinoma of Urinary Bladder: Histopathological and Immunohistochemical Study
ArticleRole of YAP1 and Tumor Associated Macrophages (TAMs) in Urothelial Carcinoma of Urinary Bladder: Histopathological and Immunohistochemical Study
ArticleImmunohistochemical expression of matrix metalloproteinase-9 in urothelial carcinoma of urinary bladder
ArticleImmunohistochemical expression of matrix metalloproteinase-9 in urothelial carcinoma of urinary bladder